en · de · es · fr · pt
epitalon-notes.peptides6908.com › News › Peptide Identity And Laboratory Handling — Complete Guide

Peptide Identity And Laboratory Handling — Complete Guide

By Editorial Desk · published 2026-01-27 · last reviewed 2026-03-03 · News

Epithalamin is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-03-03. Numbers and descriptions here follow the published literature rather than marketing material.

Peptide Identity and Laboratory Handling

Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.

Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.

Origin and Telomerase Research Claims

Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.

The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.

Epitalon at a glance

PropertyValueNotes
Molecular formulaC14H22N4O9Free acid form of the tetrapeptide
Molecular massAbout 390.35 DaCalculated monoisotopic value
AppearanceWhite to off-white powderTypical lyophilized presentation
SolubilitySoluble in waterAlso dissolves in buffered saline
Storage temperatureMinus 20 degrees CelsiusDry, dark conditions; avoid repeated thawing

Identity and Research Background

Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.

The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.

Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.

Related pages on this site

Analytical Verification and Storage

The molecule is a short, linear, hydrophilic peptide that dissolves readily in water or aqueous buffer. Its principal chemical liabilities are hydrolytic rather than oxidative, since it contains no cysteine, methionine, or tryptophan residues. The aspartate–glycine step is a recognised site for aspartimide formation under mildly acidic or basic conditions, generating isoaspartate and succinimide-related products over time. Desiccated lyophilised powder held at −20 °C is comparatively stable, whereas dilute solutions degrade faster and are best frozen as single-use aliquots rather than thawed repeatedly.

No pharmacopoeial monograph exists for this peptide, so quality rests on the supplier's internal specifications and on whatever independent testing a purchaser arranges. Certificates of analysis differ widely in which tests they report and in the limits applied. The counter-ion introduced during purification, commonly acetate or trifluoroacetate, changes the net peptide content of a given mass of powder, so two samples of equal weight may not contain equal amounts of the active sequence. Third-party laboratories can verify purity, identity, residual solvents, and counter-ion content for a fee, which makes documentation more informative than labelling.

Epitalon Background And Identification

Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.

The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.

Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.

Analytical Methods And Handling

Documentation accompanying research peptides usually includes a certificate of analysis listing the batch number, purity figure, and test methods applied. Buyers comparing suppliers should check whether the reported purity refers to chromatographic area or to a mass-balance calculation, because the two are not equivalent. Counter-ion content, residual solvents, and water content are sometimes omitted from such certificates even though they affect the actual peptide mass present. Independent verification through a second laboratory is the most direct way to confirm that a supplied material matches its label.

Purity assessment of peptide reagents normally relies on reversed-phase high-performance liquid chromatography. A gradient of acetonitrile in water with trifluoroacetic acid, paired with a C18 stationary phase, separates the target tetrapeptide from truncated sequences and deletion analogues. Detection at 214 nanometres exploits absorbance of the peptide backbone, since the molecule contains no aromatic residue. Results are expressed as a percentage of total peak area. Values above ninety-five percent are typical for research-grade material, although reporting conventions vary between suppliers.

Background from the literature

727.6 Rupture of tendon, nontraumatic 727.62 Rupture, biceps tendon 727.67 Rupture, achilles tendon 727.8 Other disorders of synovium, tendon, and bursa 727.83 Plica syndrome 727.89 Abscess, bursa 728 Disorders of muscle, ligament, and fascia 728.0 Infective myositis 728.1 Muscular calcification and ossification 728.2 Muscular wasting, atrophy 728.3 Other specific muscle disorders 728.4 Laxity of ligament 728.5 Hypermobility syndrome 728.6 Dupuytren's contracture 728.7 Other fibromatoses 728.71 Plantar fasciitis 728.8 Other disorders of muscle, ligament, and fascia 728.84 Diastasis recti 728.85 Muscle spasm 728.86 Necrotizing fasciitis 728.87 Muscle weakness 728.88 Rhabdomyolysis 728.89 Iliotibial band syndrome 729 Other disorders of soft tissues 729.0 Rheumatism unspecified and fibrositis 729.1 Myalgia and myositis, Fibromyositis 729.2 Neuralgia neuritis and radiculitis unspecified 729.3 Panniculitis unspecified 729.4 Fasciitis unspecified 729.5 Pain in limb 729.6 Foreign body in soft tissue 729.7 Nontraumatic compartment syndrome

In 2016, General Electric announced a sCO2-based turbine that enabled a 50% efficiency of converting heat energy to electrical energy. In it the CO2 is heated to 700 °C. It requires less compression and allows heat transfer. It reaches full power in 2 minutes, whereas steam turbines need at least 30 minutes. The prototype generated 10 MW and is approximately 10% the size of a comparable steam turbine. The 10 MW US$155-million Supercritical Transformational Electric Power (STEP) pilot plant was completed in 2023 in San Antonio. It is the size of a desk and can power around 10,000 homes. In 2025, The Nuclear Power Institute of China (NPIC) of the China National Nuclear Corporation (CNNC) and its partners have commissioned the world's first commercial supercritical CO2 system - Chaotan One - with a capacity of 2 x 15 MW, utilizing waste heat from a steel factory in Liupanshui, Guizhou Province.

== In-gel digestion == Afterwards the eponymous step of the method is performed, the in-gel digestion of the proteins. By this procedure, the protein is cut enzymatically into a limited number of shorter fragments. These fragments are called peptides and allow for the identification of the protein with their characteristic mass and pattern. The serine protease trypsin is the most common enzyme used in protein analytics. Trypsin cuts the peptide bond specifically at the carboxyl end of the basic aminoacids arginine and lysine. If there is an acidic amino acid like aspartic acid or glutamic acid in direct neighborhood to the cutting site, the rate of hydrolysis is diminished, a proline C-terminal to the cutting site inhibits the hydrolysis completely. An undesirable side effect of the use of proteolytic enzymes is the self digestion of the protease. To avoid this, in the past Ca2+-ions were added to the digestion buffer. Nowadays most suppliers offer modified trypsin where selective methylation of the lysines limits the autolytic activity to the arginine cutting sites. Unmodified trypsin has its highest activity between 35 °C and 45 °C. After the modification, the optimal temperature is changed to the range of 50 °C to 55 °C. Other enzymes used for in-gel digestion are the endoproteases Lys-C, Glu-C, Asp-N and Lys-N. These proteases cut specifically at only one amino acid e.g. Asp-N cuts n-terminal of aspartic acid. Therefore, a lower number of longer peptides is obtained.

Sources: en.wikipedia.org

Further detail

=== Timing === Newborn babies usually breastfeed 8 to 12 times every 24 hours, and they typically express hunger cues every one to three hours for the first two to four weeks of their lives. A newborn has a small stomach capacity, approximately 20 mL. The amount of breast milk that is produced is timed to meet the infant's needs in that the first milk, colostrum, is concentrated but produced in only very small amounts, gradually increasing in volume to meet the expanding size of the infant's stomach capacity. Cluster feeding may occur for several months, whereby infants will feed very frequently (every 30 minutes to 1 hour), usually associated with developmental milestones. Many newborns typically feed for 10 to 15 minutes on each breast; however, feeds may last up to 45 minutes, depending on the infant's alertness and efficiency. Nutritive sucking follows a slow, rhythmic pattern, with one to two sucks per swallow. Non-nutritive sucking is a faster-paced sucking pattern with few swallows. This swallow pattern is often observed at the beginning or the end of a feed. At the beginning of the feed, this pattern triggers milk letdown, while at the end of the feed, this may signal that the infant is tired or becoming relaxed with a slower milk velocity.

During a match against Borussia Mönchengladbach in 1996, Wenger presided over Rice's caretaker duties at Arsenal, and ordered the team to switch from their preferred 3–5–2 formation to 4–4–2. The tactical change did not have its desired effect, as Arsenal lost the game having led before Wenger's half-time instruction. For much of the 1996–97 season, Arsenal continued to play 3–5–2 as it was the only formation the defenders were comfortable with, as well as injuries unsettling the side. In Wenger's second season at the club, he reinstated 4–4–2 and focused on strengthening the front six, by signing wingers Overmars and Luís Boa Morte and partnering Vieira with Petit. According to Jonathan Wilson, the system was similar to 4–3–3, as Overmars often pushed higher up the field and Parlour played alongside Vieira and Petit to solidify the midfield. Needing to compensate deficiencies in attack the following season, Wenger relied on his experienced defence to direct games, which conceded 17 goals in 38 league matches. From then on, Wenger deployed an unconventional 4–4–2 with a greater emphasis on attack and movement; his teams between 2001 and 2004 were dominant on the left flank. By the 2005–06 season, clubs in England were increasingly in favour of using the 4–5–1 system. Wenger, having earlier suggested he would never resort to a negative system, later adopted the formation for Champions League matches. The decision to pack the midfield and play a lone striker resulted in Arsenal reaching the final.

Lex Politica also represented the non-profit arm in the US of Victor Orban's Danube Institute. Gober was also involved in the 2025 redistricting process. Republican mapmaker Kincaid testified that the Republican National Committee retained Gober to represent the Texas Republican congressional delegation and that Gober conveyed the delegation's requests to him during the map-drawing process. Gober's congressional campaign subsequently listed his redistricting work among his accomplishments, stating that he had helped deliver a redistricting plan that strengthened the Republican majority and describing the result as having "Secured Five New Republican Seats." Gober won the Republican nomination for Texas’ redrawn 10th Congressional District with 51.2 percent of the vote, narrowly avoiding a runoff. Gober is running on a platform of strict border security, “America First” economic policies, and the “weaponization of government” against conservative causes. The incumbent is Republican Michael McCaul, who was re-elected in 2024 with 63.6% of the vote. McCaul is not seeking reelection in the redrawn district, which gave 60.5% of the vote to Donald Trump and 58.4% to Ted Cruz in 2024.

Sources: en.wikipedia.org

Background from the literature

Valve president and Half-Life director Gabe Newell coined the name "Gordon Freeman" during a conversation with the game's writer Marc Laidlaw in his car. Laidlaw had originally named the character "Dyson Poincaré", combining the names of physicist and philosopher Freeman Dyson and mathematician Henri Poincaré. The texture for Gordon's head was "too big of a job for just one person", so Valve designers combined references from four people. An earlier model of Gordon, known as "Ivan the Space Biker", had a full beard that was subsequently trimmed. Other iterations of Gordon's concept featured different glasses, a ponytail, and a helmet. Gordon wears a special full-body hazmat suit, known as the Hazardous Environment Suit (or HEV Suit). The suit is designed to protect the user from radiation, energy discharges, and blunt trauma during the handling of hazardous materials. The suit's main feature is its "high-impact reactive armor", an electrically powered armor system that, when charged, absorbs two-thirds of the damage that Gordon would ordinarily suffer in Half-Life and 80% in Half-Life 2. A fully charged suit can survive several dozen hits from small arms and even one direct hit from an RPG. The suit can be charged by various means, and has its own oxygen supply and medical injectors, such as morphine and a neurotoxin antidote. It comes with a built-in flashlight, a radio (which frequently picks up enemy communications), various tracking devices, a compass, and a Geiger counter.

The beef hormone controversy or beef hormone dispute is a disagreement over the use of growth hormones in beef production. In 1989, the European Communities banned the import of meat that contained artificial beef growth hormones, although they were approved for use in the United States. In 2003 estradiol-17β was permanently banned, while provisionally banning five others. World Trade Organization (WTO) rules permit such bans, but only where a signatory presents valid scientific evidence that the ban is a health and safety measure. Canada and the United States opposed this ban, taking the EU to the WTO Dispute Settlement Body. In 1997, the WTO Dispute Settlement Body ruled against the EU. It remains one of the most intractable agricultural trade controversies since the establishment of the WTO. It is not the same as the UK–EU dispute over bovine spongiform encephalopathy, although both have been termed the "beef war".

Meanwhile, in 169 BC, 1,500 more Latin colonists with their families, led by the triumvirate of Titus Annius Lucius, Publius Decius Subulo, and Marcus Cornelius Cethegus, settled in the town as a reinforcement to the garrison. The discovery of the gold fields near the modern Klagenfurt in 130 BC brought the growing colony into further notice, and it soon became a place of importance, not only owing to its strategic military position, but as a centre of commerce, especially in agricultural products and viticulture. It also had, in later times at least, considerable brickfields. In 90 BC, the original Latin colony became a municipium and its citizens were ascribed to the Roman tribe Velina. The customs boundary of Italy was close by in Cicero's day. Julius Caesar visited the city on a number of occasions and pitched a winter camp nearby in 59–58 BC.

== Agricultural uses == Bioenzymes are also bio catalyst. They are prepared by fermentation of organic waste, jaggery and water in ratio 3:1:10 for three months. It increases the soil microbe population and speeds up composting and decomposition and so is included in catalyts. It heals the soil. It is one of the best best organic liquid fertilizer. It is diluted with water.

Sources: en.wikipedia.org

Frequently asked questions

What is epitalon made of?

Epitalon is a synthetic tetrapeptide built from four amino acids: alanine, glutamate, aspartate, and glycine. It is not extracted from a natural source but made in the laboratory by chemical synthesis. Its short length makes it relatively straightforward to produce at high purity.

Does epitalon occur naturally in the body?

No naturally occurring free form of the peptide has been described. The four-amino-acid sequence can appear as a fragment within larger proteins, but that is not the same as the intact compound being present as a circulating molecule. Materials used in research are synthetic.

How is epitalon purity checked?

Purity is usually checked by reverse-phase high-performance liquid chromatography, which separates the target peptide from related impurities. Mass spectrometry is commonly used alongside it to confirm molecular mass. Some suppliers also provide amino acid analysis for additional sequence confirmation.

Who developed epitalon?

Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.

Network